Global Marine Pharmaceuticals Market Growth 2024-2030

Publication ID:

LPI01242999

Publication Date:

January 11, 2024

Pages:

137

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Marine Pharmaceuticals market size was valued at US$ 28860 million in 2023. With growing demand in downstream market, the Marine Pharmaceuticals is forecast to a readjusted size of US$ 52140 million by 2030 with a CAGR of 8.8% during review period.
The research report highlights the growth potential of the global Marine Pharmaceuticals market. Marine Pharmaceuticals are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Marine Pharmaceuticals. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Marine Pharmaceuticals market.
The drug obtained from marine organisms which are being conventionally used like shark and cod-liver oils, sodium alginate, agar-agar, chitin etc.

Marine organisms are potential source for drug discovery. Life has originated from the oceans that cover over 70% of the surface of earth and contain highly ecological, chemical and biological diversity starting from micro-organisms to vertebrates. This diversity has been the source of unique chemical compounds, which hold tremendous pharmaceutical potential.
Global Marine Pharmaceuticals key players include Seattle Genetics, Inc., DSM, Eisai Co, Takeda, BASF, Amway, etc. Global top six manufacturers hold a share about 10%.
North America is the largest market, with a share about 35%, followed by Europe and China, both have a share over 35 percent.
In terms of product, Health Supplement is the largest segment, with a share about 90%. And in terms of application, the largest application is Pharmacy, followed by Hospital & Clinic.
Key Features:
The report on Marine Pharmaceuticals market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Marine Pharmaceuticals market. It may include historical data, market segmentation by Type (e.g., Drugs, Health Supplement), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Marine Pharmaceuticals market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Marine Pharmaceuticals market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Marine Pharmaceuticals industry. This include advancements in Marine Pharmaceuticals technology, Marine Pharmaceuticals new entrants, Marine Pharmaceuticals new investment, and other innovations that are shaping the future of Marine Pharmaceuticals.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Marine Pharmaceuticals market. It includes factors influencing customer ' purchasing decisions, preferences for Marine Pharmaceuticals product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Marine Pharmaceuticals market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Marine Pharmaceuticals market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Marine Pharmaceuticals market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Marine Pharmaceuticals industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Marine Pharmaceuticals market.
Market Segmentation:
Marine Pharmaceuticals market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Drugs
Health Supplement
Segmentation by application
Hospital & Clinic
Pharmacy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Seattle Genetics
DSM
Eisai Co
Takeda
BASF
Amway
Pfizer
Pelagia (EPAX)
Pharma Mar SA
Croda
GNC
GSK
TerSera Therapeutics
Nordic Naturals
Carlson Labs
Key Questions Addressed in this Report
What is the 10-year outlook for the global Marine Pharmaceuticals market?
What factors are driving Marine Pharmaceuticals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Marine Pharmaceuticals market opportunities vary by end market size?
How does Marine Pharmaceuticals break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Marine Pharmaceuticals Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Marine Pharmaceuticals by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Marine Pharmaceuticals by Country/Region, 2019, 2023 & 2030
2.2 Marine Pharmaceuticals Segment by Type
2.2.1 Drugs
2.2.2 Health Supplement
2.3 Marine Pharmaceuticals Sales by Type
2.3.1 Global Marine Pharmaceuticals Sales Market Share by Type (2019-2024)
2.3.2 Global Marine Pharmaceuticals Revenue and Market Share by Type (2019-2024)
2.3.3 Global Marine Pharmaceuticals Sale Price by Type (2019-2024)
2.4 Marine Pharmaceuticals Segment by Application
2.4.1 Hospital & Clinic
2.4.2 Pharmacy
2.4.3 Other
2.5 Marine Pharmaceuticals Sales by Application
2.5.1 Global Marine Pharmaceuticals Sale Market Share by Application (2019-2024)
2.5.2 Global Marine Pharmaceuticals Revenue and Market Share by Application (2019-2024)
2.5.3 Global Marine Pharmaceuticals Sale Price by Application (2019-2024)
3 Global Marine Pharmaceuticals by Company
3.1 Global Marine Pharmaceuticals Breakdown Data by Company
3.1.1 Global Marine Pharmaceuticals Annual Sales by Company (2019-2024)
3.1.2 Global Marine Pharmaceuticals Sales Market Share by Company (2019-2024)
3.2 Global Marine Pharmaceuticals Annual Revenue by Company (2019-2024)
3.2.1 Global Marine Pharmaceuticals Revenue by Company (2019-2024)
3.2.2 Global Marine Pharmaceuticals Revenue Market Share by Company (2019-2024)
3.3 Global Marine Pharmaceuticals Sale Price by Company
3.4 Key Manufacturers Marine Pharmaceuticals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Marine Pharmaceuticals Product Location Distribution
3.4.2 Players Marine Pharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Marine Pharmaceuticals by Geographic Region
4.1 World Historic Marine Pharmaceuticals Market Size by Geographic Region (2019-2024)
4.1.1 Global Marine Pharmaceuticals Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Marine Pharmaceuticals Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Marine Pharmaceuticals Market Size by Country/Region (2019-2024)
4.2.1 Global Marine Pharmaceuticals Annual Sales by Country/Region (2019-2024)
4.2.2 Global Marine Pharmaceuticals Annual Revenue by Country/Region (2019-2024)
4.3 Americas Marine Pharmaceuticals Sales Growth
4.4 APAC Marine Pharmaceuticals Sales Growth
4.5 Europe Marine Pharmaceuticals Sales Growth
4.6 Middle East & Africa Marine Pharmaceuticals Sales Growth
5 Americas
5.1 Americas Marine Pharmaceuticals Sales by Country
5.1.1 Americas Marine Pharmaceuticals Sales by Country (2019-2024)
5.1.2 Americas Marine Pharmaceuticals Revenue by Country (2019-2024)
5.2 Americas Marine Pharmaceuticals Sales by Type
5.3 Americas Marine Pharmaceuticals Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Marine Pharmaceuticals Sales by Region
6.1.1 APAC Marine Pharmaceuticals Sales by Region (2019-2024)
6.1.2 APAC Marine Pharmaceuticals Revenue by Region (2019-2024)
6.2 APAC Marine Pharmaceuticals Sales by Type
6.3 APAC Marine Pharmaceuticals Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Marine Pharmaceuticals by Country
7.1.1 Europe Marine Pharmaceuticals Sales by Country (2019-2024)
7.1.2 Europe Marine Pharmaceuticals Revenue by Country (2019-2024)
7.2 Europe Marine Pharmaceuticals Sales by Type
7.3 Europe Marine Pharmaceuticals Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Marine Pharmaceuticals by Country
8.1.1 Middle East & Africa Marine Pharmaceuticals Sales by Country (2019-2024)
8.1.2 Middle East & Africa Marine Pharmaceuticals Revenue by Country (2019-2024)
8.2 Middle East & Africa Marine Pharmaceuticals Sales by Type
8.3 Middle East & Africa Marine Pharmaceuticals Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Marine Pharmaceuticals
10.3 Manufacturing Process Analysis of Marine Pharmaceuticals
10.4 Industry Chain Structure of Marine Pharmaceuticals
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Marine Pharmaceuticals Distributors
11.3 Marine Pharmaceuticals Customer
12 World Forecast Review for Marine Pharmaceuticals by Geographic Region
12.1 Global Marine Pharmaceuticals Market Size Forecast by Region
12.1.1 Global Marine Pharmaceuticals Forecast by Region (2025-2030)
12.1.2 Global Marine Pharmaceuticals Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Marine Pharmaceuticals Forecast by Type
12.7 Global Marine Pharmaceuticals Forecast by Application
13 Key Players Analysis
13.1 Seattle Genetics
13.1.1 Seattle Genetics Company Information
13.1.2 Seattle Genetics Marine Pharmaceuticals Product Portfolios and Specifications
13.1.3 Seattle Genetics Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Seattle Genetics Main Business Overview
13.1.5 Seattle Genetics Latest Developments
13.2 DSM
13.2.1 DSM Company Information
13.2.2 DSM Marine Pharmaceuticals Product Portfolios and Specifications
13.2.3 DSM Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 DSM Main Business Overview
13.2.5 DSM Latest Developments
13.3 Eisai Co
13.3.1 Eisai Co Company Information
13.3.2 Eisai Co Marine Pharmaceuticals Product Portfolios and Specifications
13.3.3 Eisai Co Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Eisai Co Main Business Overview
13.3.5 Eisai Co Latest Developments
13.4 Takeda
13.4.1 Takeda Company Information
13.4.2 Takeda Marine Pharmaceuticals Product Portfolios and Specifications
13.4.3 Takeda Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Takeda Main Business Overview
13.4.5 Takeda Latest Developments
13.5 BASF
13.5.1 BASF Company Information
13.5.2 BASF Marine Pharmaceuticals Product Portfolios and Specifications
13.5.3 BASF Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 BASF Main Business Overview
13.5.5 BASF Latest Developments
13.6 Amway
13.6.1 Amway Company Information
13.6.2 Amway Marine Pharmaceuticals Product Portfolios and Specifications
13.6.3 Amway Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Amway Main Business Overview
13.6.5 Amway Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Marine Pharmaceuticals Product Portfolios and Specifications
13.7.3 Pfizer Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Pelagia (EPAX)
13.8.1 Pelagia (EPAX) Company Information
13.8.2 Pelagia (EPAX) Marine Pharmaceuticals Product Portfolios and Specifications
13.8.3 Pelagia (EPAX) Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Pelagia (EPAX) Main Business Overview
13.8.5 Pelagia (EPAX) Latest Developments
13.9 Pharma Mar SA
13.9.1 Pharma Mar SA Company Information
13.9.2 Pharma Mar SA Marine Pharmaceuticals Product Portfolios and Specifications
13.9.3 Pharma Mar SA Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Pharma Mar SA Main Business Overview
13.9.5 Pharma Mar SA Latest Developments
13.10 Croda
13.10.1 Croda Company Information
13.10.2 Croda Marine Pharmaceuticals Product Portfolios and Specifications
13.10.3 Croda Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Croda Main Business Overview
13.10.5 Croda Latest Developments
13.11 GNC
13.11.1 GNC Company Information
13.11.2 GNC Marine Pharmaceuticals Product Portfolios and Specifications
13.11.3 GNC Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 GNC Main Business Overview
13.11.5 GNC Latest Developments
13.12 GSK
13.12.1 GSK Company Information
13.12.2 GSK Marine Pharmaceuticals Product Portfolios and Specifications
13.12.3 GSK Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 GSK Main Business Overview
13.12.5 GSK Latest Developments
13.13 TerSera Therapeutics
13.13.1 TerSera Therapeutics Company Information
13.13.2 TerSera Therapeutics Marine Pharmaceuticals Product Portfolios and Specifications
13.13.3 TerSera Therapeutics Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 TerSera Therapeutics Main Business Overview
13.13.5 TerSera Therapeutics Latest Developments
13.14 Nordic Naturals
13.14.1 Nordic Naturals Company Information
13.14.2 Nordic Naturals Marine Pharmaceuticals Product Portfolios and Specifications
13.14.3 Nordic Naturals Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Nordic Naturals Main Business Overview
13.14.5 Nordic Naturals Latest Developments
13.15 Carlson Labs
13.15.1 Carlson Labs Company Information
13.15.2 Carlson Labs Marine Pharmaceuticals Product Portfolios and Specifications
13.15.3 Carlson Labs Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Carlson Labs Main Business Overview
13.15.5 Carlson Labs Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂